PARKINSON'S DISEASE – D. Berg, R. Krüger, O. Rieß, and P. Riederer -- DIAGNOSIS AND NEUROPROTECTION IN PARKINSON'S DISEASE – T. Müller -- UPDATE ON PARKINSON'S DISEASE GENETICS - R. Krüger, D. Berg, O. Rieß, and P. Riederer -- LRRK2-ASSOCIATED PARKINSONISM – M. Toft, M. J. Farrer, J. O. Aasly, D. W. Dickson, and Z. K. Wszolek -- GENE AND PROTEIN EXPRESSION PROFILING IN PARKINSON'S DISEASE: QUEST FOR NEUROPROTECTIVE DRUGS – O. Weinreb, T. Amit, E. Grünblatt, P. Riederer, M. Youdim, and S. Mandel -- NEUROPROTECTIVE MECHANISMS: OXIDATIVE STRESS AS A TARGET FOR NEUROPROTECTIVE THERAPIES IN ALZHEIMER'S AND PARKINSON'S DISEASE – A. Huber, A. Bürkle, and G. Münch -- DRUG TREATMENT OF MOTOR SYMPTOMS IN PARKINSON'S DISEASE – T. Müller -- PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION – F. Geser, S. W. Scholz, and G. K. Wenning -- CENTRAL TREMORS – T. Glöckler and H. Reichmann -- MOLECULAR MECHANISMS OF METHAMPHETAMINE-INDUCED NEUROTOXICITY: INSIGHTS OBTAINED THROUGH cDNA ARRAY ANALYSES – S. Jayanthi, M. T. McCoy, and J. L. Cadet -- HUNTINGTON'S DISEASE: UNRAVELING THE PATHOPHYSIOLOGICAL CASCADE BEHIND A SINGULAR GENE DEFECT – C. M. Kosinski, B. Landwehrmeyer, and A. Ludolph -- DEMENTIA: THE SIGNIFICANCE OF CEREBRAL METABOLIC DISTURBANCES IN ALZHEIMER'S DISEASE. RELATION TO PARKINSON'S DISEASE – S. Hoyer and L. Frölich -- PROTEOMICS ANALYSIS IN ALZHEIMER'S DISEASE: NEW INSIGHTS INTO MECHANISMS OF NEURODEGERATION – D. A. Butterfield and R. Sultana -- VASCULAR DEMENTIA – A. Cagnin and L. Battistin -- LEWY BODY DISORDERS – K. A. Jellinger -- GENE HUNTING BY SUBSTRACTIVE HYBRIDIZATION IN DOWN SYNDROME CORRELATION WITH PROTEOMICS ANALYSIS – O. Golubnitschaja and M. Fountoulakis -- HIV DEMENTIA: A NEURODEGENERATIVE DISORDER WITH VIRAL ETIOLOGY – E. Koutsilieri, G. Arendt, E. Neuen-Jacob, C. Scheller, E. Grünblatt, and P. Riederer -- MULTIPLE SCLEROSIS AND AUTOIMMUNE ENCEPHALOMYELITIS – H. Lassmann -- NEUROPATHIC PAIN – C. Briani, L. Padua, C. Pazaglia, and L. Battistin.